Abstracts
Abstract Submissions Closed
Abstract Submissions
We are delighted to announce that abstract submissions are now open for the 2023 ACTA International Clinical Trials Symposium.
The conference will be held on 27 – 29 November 2023, at the Park Hyatt in Melbourne.
The ACTA 2023 Steering Committee invites authors to submit abstracts for presentations within any of the ACTA 2023 themes. Submissions are sought for oral, workshop and poster presentations and can be made by clicking the download tab below.
The theme of the symposium is Efficiency and Impact: Changing the landscape in clinical trials and we invite abstracts that address the following themes:
Enhancing efficiency through innovative trial designs.
Collaboration and partnership to increase research impact.
Consumer engagement: shaping the future of research.
Embedding to enhance research efficiency.
Consumer engagement: shaping the future of research.
Embedding to enhance research efficiency.
Enhancing efficiency through innovative trial designs.
Collaboration and partnership to increase research impact.
Abstract Submission Form
Please submit your abstract form to events@clinicaltrialsalliance.org.au
2023 Abstract Submission Information
Submission Guidelines
Oral Presentations, Workshops and Posters
ACTA Members:
Oral presentations are usually 15 minutes or as appropriate for the program.
Posters:
Poster presentations will be accepted at this years conference.
Audiovisual Equipment
Each lecture room will be equipped for the presentation of PowerPoint slides and include a data projector, laptop, lectern and microphone. Multimedia clips should be embedded in your slides. Other audio-visual aids, such as overhead projectors, are not available.
All presentations must be digital in either PowerPoint or Keynote. Speakers will be required to bring their presentations on a USB stick with them to the conference. Presentations must be given at least three (3) hours prior to the start of the session in which you are presenting. It is not good practice changing computer connections at the lectern so presenting on your own laptop is not permitted.
Submission
All abstracts are to be submitted via email to events@clinicaltrialsalliance.org.au. Do NOT include symbols, tables, pictures or diagrams within the ‘content’ of your abstract to avoid formatting errors.
Selection and Notification
The ACTA International Clinical Trials Symposium Convener serves as the head of the Steering Committee and will make the final decision on which abstracts are accepted.
Abstracts will be reviewed against the following criteria:
Completed rather than future work (i.e. final results)
Original data of high quality
An analysis that extends existing knowledge
Diversity and consumer involvement
Clarity of methodology, analysis and presentation of results
Specific rather than general findings
Results of the abstract review will be sent to the contact author by 6 September 2023. Presenting authors will be notified after the closing date regarding the status of their abstract. All presenters will be required to register for the conference and pay the appropriate registration fees should they be selected. All presenters also need to meet their own travel and accommodation costs.
* Please note that all successful delegates presenting abstracts are required to register under the relevant delegate category for the event. A discounted early bird code will be provided to you upon approval of your abstract which will allow you to register at the discounted rate regardless of your registration date.
Abstract Preparation
| Length | Maximum 300 words (excluding references) |
|---|---|
|
Title |
Limited to 20 words in sentence case (i.e. capital letters are used for the first letter of the first work and proper nouns; all other words are lower case. |
|
Author and Co-Authors’ details |
Include all authors. The first author will be presumed to be the presenting author unless otherwise specified at abstract submission. |
|
Required abstract structure |
Organise the abstract as follows:
• Aim (State concisely why the study was conducted)
• Method (Indicate the locale, sample number, principal test(s) performed, and the types of statistical analysis employed)
• Results (Confirm or refute the hypothesis, supported by statistics if appropriate)
• Conclusion (State the effect of the study on future patient management or the understanding of basic processes)
• References (Include up to 3 references if applicable)
|
Submission Details
Submit your completed abstract submission to events@clinicaltrialsalliance.org.au by 11:59 pm AEST (midnight) on Friday 14 July 2023.
You will receive an email acknowledging receipt within five working days.